tradingkey.logo
tradingkey.logo
Search

Xenetic Biosciences Inc

XBIO
Add to Watchlist
2.550USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
5.85MMarket Cap
LossP/E TTM

XBIO Financials

See Xenetic Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Xenetic Biosciences Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.20/--
Revenue / Forecast
806.92K/--
Period
FY2025 Earnings
Revenue(YoY)
2.98M
19.04%
EPS(YoY)
-1.58
38.68%
Analyst Rating
2025/11/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
65.99%-0.20
61.15%-0.27
-16.75%-0.33
45.99%-0.45
24.50%-0.59
10.19%-0.68
58.88%-0.28
-19.95%-0.83
-37.34%-0.78
22.63%-0.76
---0.69
---0.69
---0.56
---0.98
---3.64
----
----
----
----
----
Revenue
36.01%806.92K
18.11%766.30K
67.19%1.03M
-18.79%589.90K
16.14%593.26K
-3.44%648.82K
0.50%614.24K
11.58%726.40K
-15.69%510.82K
37.99%671.96K
47.54%611.17K
56.22%651.00K
55.75%605.84K
46.41%486.97K
18.60%414.25K
44.89%416.71K
103.43%388.99K
119.78%332.60K
201.27%349.27K
154.68%287.60K
Net Profit
49.47%-456.38K
45.09%-579.08K
-16.78%-509.94K
45.94%-688.70K
24.43%-903.14K
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.20M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
-18.40%-1.59M
-53.47%-1.84M
82.13%-1.35M
-16.05%-1.11M
Net Margin
62.85%-56.56%
53.50%-75.57%
30.15%-49.66%
33.43%-116.75%
34.93%-152.23%
6.78%-162.53%
58.84%-71.09%
-8.64%-175.38%
-65.48%-233.96%
42.73%-174.34%
---172.71%
---161.44%
---141.38%
---304.44%
---415.57%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Revenue
36.01%806.92K
18.11%766.30K
67.19%1.03M
-18.79%589.90K
16.14%593.26K
-3.44%648.82K
0.50%614.24K
11.58%726.40K
-15.69%510.82K
37.99%671.96K
47.54%611.17K
56.22%651.00K
55.75%605.84K
46.41%486.97K
18.60%414.25K
44.89%416.71K
103.43%388.99K
119.78%332.60K
201.27%349.27K
154.68%287.60K
Operating profit
46.72%-502.12K
43.32%-623.03K
-9.06%-544.73K
45.83%-724.41K
25.70%-942.41K
12.47%-1.10M
56.44%-499.47K
-11.62%-1.34M
-38.60%-1.27M
19.68%-1.26M
-35.26%-1.15M
55.41%-1.20M
43.50%-915.17K
16.58%-1.56M
38.39%-847.79K
-138.29%-2.69M
-18.31%-1.62M
-53.61%-1.87M
-9.10%-1.38M
-14.78%-1.13M
Net Profit
49.47%-456.38K
45.09%-579.08K
-16.78%-509.94K
45.94%-688.70K
24.43%-903.14K
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.20M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
-18.40%-1.59M
-53.47%-1.84M
82.13%-1.35M
-16.05%-1.11M
Current assets
38.66%7.60M
22.20%8.05M
-27.89%5.07M
-33.20%5.35M
-34.61%5.48M
-31.29%6.59M
-37.57%7.03M
-33.46%8.01M
-34.93%8.38M
-29.78%9.59M
-20.54%11.26M
-21.67%12.04M
-23.79%12.87M
-27.08%13.65M
-31.16%14.17M
50.76%15.38M
53.03%16.89M
51.37%18.72M
157.52%20.58M
11.89%10.20M
Total current liabilities
43.46%958.24K
8.25%968.02K
10.14%1.11M
-43.09%903.43K
-6.78%667.93K
10.46%894.26K
-5.53%1.01M
82.21%1.59M
-16.33%716.49K
-24.56%809.59K
1.68%1.07M
-31.89%871.32K
-19.46%856.37K
-24.48%1.07M
-6.30%1.05M
33.50%1.28M
33.21%1.06M
51.68%1.42M
42.24%1.12M
21.70%958.21K
Total assets
36.57%7.91M
21.19%8.36M
-37.01%5.07M
-40.73%5.35M
-38.35%5.79M
-34.92%6.90M
-32.73%8.05M
-29.15%9.03M
-31.51%9.39M
-27.96%10.61M
-23.19%11.96M
-22.58%12.75M
-23.73%13.72M
-25.71%14.72M
-26.84%15.57M
50.87%16.47M
52.90%17.98M
50.35%19.82M
144.76%21.29M
-42.74%10.92M
Total liabilities
43.46%958.24K
8.25%968.02K
10.14%1.11M
-43.09%903.43K
-6.78%667.93K
10.46%894.26K
-5.53%1.01M
82.21%1.59M
-16.33%716.49K
-24.56%809.59K
1.68%1.07M
-31.89%871.32K
-19.46%856.37K
-24.48%1.07M
-6.30%1.05M
32.40%1.28M
30.34%1.06M
47.42%1.42M
42.24%1.12M
-73.93%966.17K
Total equity
35.67%6.95M
23.12%7.40M
-43.78%3.96M
-40.23%4.45M
-40.96%5.12M
-38.67%6.01M
-35.40%7.04M
-37.31%7.45M
-32.52%8.68M
-28.22%9.80M
-24.99%10.89M
-21.80%11.88M
-24.00%12.86M
-25.81%13.65M
-27.98%14.52M
52.67%15.19M
54.58%16.92M
50.58%18.39M
154.98%20.16M
-35.22%9.95M
Net operating income
46.46%-536.38K
63.99%-242.68K
-43.40%-658.25K
26.90%-383.83K
13.58%-1.00M
15.01%-673.99K
51.66%-459.04K
58.62%-525.10K
-5.16%-1.16M
-5.61%-793.03K
12.01%-949.63K
-74.11%-1.27M
47.19%-1.10M
48.52%-750.91K
-4.44%-1.08M
-0.29%-728.90K
-37.42%-2.09M
-52.96%-1.46M
-2.10%-1.03M
44.12%-726.81K
Net investment
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
---500.00K
----
----
----
----
Net financing
----
--4.00M
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
--11.45M
----

FAQs

What is the total revenue of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its total revenue reached 2.98M, with a year-on-year change of 2.50M.

What are the current assets of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its current assets were 8.05M, with a year-on-year change of 22.20.

What are the total assets of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its total assets of Xenetic Biosciences Inc were 8.36M, with a year-on-year change of 21.19.

What are the total liabilities of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its total liabilities of Xenetic Biosciences Inc were 968.02K, with a year-on-year change of 8.25.

What is the total equity of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its total equity of Xenetic Biosciences Inc was 7.40M, with a year-on-year change of 23.12.

What is the net operating income of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its net operating income of Xenetic Biosciences Inc was -2.83M, with a year-on-year change of 19.01.

What is the Earnings Per Share (EPS) of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.58, with a year-on-year change of 38.68.

What is the net income of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its net income was -2.68M, with a year-on-year change of 32.31.

What is the net margin of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its net profit margin was -90.07, with a year-on-year change of 43.13.

What is the Return on Equity (ROE) of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -40.01, with a year-on-year change of 20.18.

What is the Return on Assets (ROA) of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.12, with a year-on-year change of 22.37.

What is the operating profit of Xenetic Biosciences Inc?

According to Xenetic Biosciences Inc's FY2025 earnings report, its operating profit was -2.83M, with a year-on-year change of 19.01.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.